Onsdag 16 September | 17:35:39 Europe / Stockholm
Est. tid*
2027-02-11 07:45 Bokslutskommuniké 2026
2026-10-22 07:45 Kvartalsrapport 2026-Q3
2026-07-17 - Kvartalsrapport 2026-Q2
2026-04-30 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2026-04-29 - Årsstämma
2026-04-29 - Kvartalsrapport 2026-Q1
2026-02-12 - Bokslutskommuniké 2025
2025-10-22 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-06-11 - Extra Bolagsstämma 2025
2025-04-30 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2025-04-29 - Årsstämma
2025-04-29 - Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2024-05-22 - Årsstämma
2024-05-02 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-08 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-06-02 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2023-06-02 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-03-24 - Extra Bolagsstämma 2023
2023-03-08 - Bokslutskommuniké 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-10-03 - Extra Bolagsstämma 2022
2022-08-24 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-03-09 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Vimian Group är en koncern verksam inom djurhälsa. Bolaget levererar, via sina dotterbolag, läkemedel och tekniska lösningar till veterinärer, laboratorier och husdjursägare. Produkterna inkluderar exempelvis läkemedel med tillhörande klinisk forskning samt digitala plattformar för veterinärkliniker. Bolaget är verksamma på en global nivå med huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Change to the Vimian Group AB (publ) management team and appointment of new Head of M&A

2026-09-14 11:00:00

Vimian Group AB (publ) (“Vimian”) appoints Andrea Tidholm as new Head of M&A, reporting to CFO Carl-Johan Zetterberg Boudrie, effective 5 October. Andrea Tidholm has twenty years of M&A experience and joined Vimian in 2022. Martin Bengtson, current Head of M&A and member of the Vimian Group management team, has decided to step down from his position to pursue new opportunities outside the company.

Andrea Tidholm (45) has twenty years of M&A experience from various industries and is currently M&A Director for Vimian’s Veterinary Services segment since 2022. Andrea Tidholm holds a Master’s degree in Finance from Stockholm School of Economics.

“We are pleased to appoint Andrea Tidholm new Head of M&A, ensuring continuity and speed in the execution of our active pipeline. Andrea has significant M&A experience from animal health as well as from other industries, and is since several years a highly valued senior team member with strong business acumen and drive”, says Alireza Tajbakhsh, CEO Vimian Group, and continues:

I would like to sincerely thank Martin Bengtson for his significant achievements over the past five and a half years. During his tenure, we have completed 46 acquisitions, adding more than EUR 170 million in revenues, and developed a highly active pipeline of successful companies and entrepreneurs in animal health.”

Martin Bengtson will remain in the company until year-end. Following these changes, the Vimian Group management team will consist of eight members.